Comerica Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-491
| Closed | -$2.57K | – | 3839 |
|
2023
Q4 | $2.57K | Sell |
491
-135
| -22% | -$706 | ﹤0.01% | 3467 |
|
2023
Q3 | $9.87K | Buy |
+626
| New | +$9.87K | ﹤0.01% | 3209 |
|
2022
Q4 | $208K | Sell |
6,345
-1,950
| -24% | -$63.9K | ﹤0.01% | 2054 |
|
2022
Q3 | $257K | Sell |
8,295
-1,310
| -14% | -$40.6K | ﹤0.01% | 1997 |
|
2022
Q2 | $418K | Sell |
9,605
-375
| -4% | -$16.3K | ﹤0.01% | 1901 |
|
2022
Q1 | $502K | Buy |
9,980
+1,080
| +12% | +$54.3K | ﹤0.01% | 1867 |
|
2021
Q4 | $414K | Sell |
8,900
-1,050
| -11% | -$48.8K | ﹤0.01% | 1930 |
|
2021
Q3 | $520K | Sell |
9,950
-419
| -4% | -$21.9K | ﹤0.01% | 1932 |
|
2021
Q2 | $504K | Sell |
10,369
-786
| -7% | -$38.2K | ﹤0.01% | 2022 |
|
2021
Q1 | $491K | Sell |
11,155
-565
| -5% | -$24.9K | ﹤0.01% | 2032 |
|
2020
Q4 | $559K | Sell |
11,720
-481
| -4% | -$22.9K | ﹤0.01% | 1971 |
|
2020
Q3 | $571K | Buy |
12,201
+1,847
| +18% | +$86.4K | ﹤0.01% | 1857 |
|
2020
Q2 | $516K | Buy |
10,354
+583
| +6% | +$29.1K | ﹤0.01% | 1850 |
|
2020
Q1 | $502K | Buy |
9,771
+299
| +3% | +$15.4K | ﹤0.01% | 1730 |
|
2019
Q4 | $520K | Buy |
9,472
+24
| +0.3% | +$1.32K | ﹤0.01% | 1876 |
|
2019
Q3 | $589K | Sell |
9,448
-100
| -1% | -$6.23K | ﹤0.01% | 1809 |
|
2019
Q2 | $520K | Sell |
9,548
-671
| -7% | -$36.5K | ﹤0.01% | 1862 |
|
2019
Q1 | $488K | Sell |
10,219
-504
| -5% | -$24.1K | ﹤0.01% | 1897 |
|
2018
Q4 | $444K | Sell |
10,723
-49
| -0.5% | -$2.03K | ﹤0.01% | 1908 |
|
2018
Q3 | $627K | Buy |
10,772
+1,930
| +22% | +$112K | 0.01% | 1801 |
|
2018
Q2 | $725K | Buy |
8,842
+130
| +1% | +$10.7K | 0.01% | 1797 |
|
2018
Q1 | $481K | Buy |
8,712
+111
| +1% | +$6.13K | ﹤0.01% | 1920 |
|
2017
Q4 | $514K | Sell |
8,601
-1,094
| -11% | -$65.4K | ﹤0.01% | 1910 |
|
2017
Q3 | $504K | Buy |
9,695
+1,469
| +18% | +$76.4K | ﹤0.01% | 1896 |
|
2017
Q2 | $599K | Sell |
8,226
-769
| -9% | -$56K | ﹤0.01% | 1779 |
|
2017
Q1 | $814K | Buy |
8,995
+550
| +7% | +$49.8K | 0.01% | 1691 |
|
2016
Q4 | $585K | Buy |
8,445
+415
| +5% | +$28.7K | ﹤0.01% | 1810 |
|
2016
Q3 | $517K | Buy |
+8,030
| New | +$517K | ﹤0.01% | 1771 |
|